The validated HCC markers consisted of 38 circulating miRNAs that were involved in molecular pathways such as p53, apoptosis signaling, Pten signaling, mTor and Erk/Mapk signaling pathways. The gene discussed is TP53; the disease is hepatocellular carcinoma.